Detailed answers about DR LEINAD ROLYAT-NACIMOD & SONS LTD, including incorporation, status, business activity, and accounts information.
When was DR LEINAD ROLYAT-NACIMOD & SONS LTD founded?
DR LEINAD ROLYAT-NACIMOD & SONS LTD was officially incorporated on 3 November 2025 and is registered under company number 16825959. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is DR LEINAD ROLYAT-NACIMOD & SONS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of DR LEINAD ROLYAT-NACIMOD & SONS LTD?
DR LEINAD ROLYAT-NACIMOD & SONS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does DR LEINAD ROLYAT-NACIMOD & SONS LTD do?
DR LEINAD ROLYAT-NACIMOD & SONS LTD operates in the following sectors: 16230 - Manufacture of other builders' carpentry and joinery, 64205 - Activities of financial services holding companies, 66110 - Administration of financial markets, 81300 - Landscape service activities. These SIC codes provide insight into the company's business activities and industry focus.
What is DR LEINAD ROLYAT-NACIMOD & SONS LTD's registered address?
The registered office address of DR LEINAD ROLYAT-NACIMOD & SONS LTD is 133 COWLEY AVENUE, CHERTSEY, ENGLAND, KT16 9JL. This is the official address filed with Companies House for legal and statutory correspondence.
Is DR LEINAD ROLYAT-NACIMOD & SONS LTD financially stable?
Financial accounts for DR LEINAD ROLYAT-NACIMOD & SONS LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.